Testing effectiveness (Phase 2)Ended earlyNCT00696943
What this trial is testing
18F ML-10 for Early Detection of Response of Brain Metastases to SRS
Who this might be right for
Metastasis to Brain of Unknown Primary
Aposense Ltd. 1
Showing 7 of 7 results